QualityStocksNewsBreaks Archives - Page 873 of 1527

ThursdayFeb 11, 2021 9:49 am

QualityStocksNewsBreaks – The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Announces Conference Call to Focus Fiscal Q3 2021 Business Results

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER), a producer of premium bottled alkaline water, flavor-infused waters, and CBD-infused products, has announced an upcoming conference call. The Feb. 16, 2021 call is scheduled to start at 5 p.m. ET and will discuss financial results and business updated for fiscal third-quarter 2021. The call will be hosted by WTER president and CEO Richard Wright and chief financial officer David Guarino. The company noted that the teleconference will include investors and analysts. Following the call, the company will also release its financial results and business update; the same information will be posted on…

ThursdayFeb 11, 2021 9:13 am

QualityStocksNewsBreaks – PowerBand Solutions Inc. (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA) Closes on Private Placement, Resulting in C$5.3 Million

PowerBand Solutions’ (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA) has announced that the company has closed on its previously announced nonbrokered private placement. As announced on Jan. 22, 2021, the placement was comprised 18,275,862 units; each unit, which included one common share of the company and one share purchase warrant of the company, was sold at $0.29. In addition, each warrant holder allows the holder to receive on common share for no additional consideration for an exercise price of $0.49 per share for up to 24 months after their date of issuance. The private placement was fully subscribed, resulting in total…

WednesdayFeb 10, 2021 3:14 pm

QualityStocksNewsBreaks – United Medical Equipment Business Solutions Network Inc. Provides Antigen Rapid POC Test as part of Comprehensive COVID-19 Strategy

United Medical Equipment (“UME,” “UMEBSNI”) is committed to offering high-quality COVID-19 services, solutions and supplies. Among these, UME provides the CareStart(TM) COVID-19 Antigen Rapid POC test. The test can be administered by authorized laboratories and at the point of care by medical professionals to detect the presence of the SARS-CoV-2 nucleocapsid protein antigen. The innovative test features a 10-minute processing time and provides the capability to identify acute infection with 88.4% sensitivity and 100% specificity. A recent article discussing this reads, “The CareStart product is part of a UME’s comprehensive COVID-19 monitoring strategy, which was carefully designed with the assistance…

WednesdayFeb 10, 2021 3:03 pm

QualityStocksNewsBreaks – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Anticipates ‘Breakout Year’ in 2021

Imagin Medical (CSE: IME) (OTCQB: IMEXF), a surgical imaging company, expects to achieve important milestones in the year ahead. The company’s proprietary i/Blue Imaging System is designed to significantly enhance surgeons’ ability to visualize and remove cancer cells using blue light by combining advanced optics and light sensors with a contrast imaging agent. The system’s key feature is its adaptability to almost any scope already in use by hospitals and surgical centers. Despite the challenges of 2020, Imagin was able to transition its product from the development stage to manufacturing, contracting with FDA registered and ISO 13485:2016-certified manufacturer Lighthouse Imaging.…

WednesdayFeb 10, 2021 2:53 pm

QualityStocksNewsBreaks – InsuraGuest Technologies Inc. (TSXV: ISGI) (OTCQB: ISGIF) Poised as Insurtech Disrupts the Insurance Industry

InsuraGuest Technologies (TSXV: ISGI) (OTCQB: ISGIF) is positioned as technology has become a key factor and is generating significant changes in the insurance industry. The combination of insurance and technology (insurtech) is disrupting the insurance industry in its entirety, delivering better processes, efficiencies and customer experiences and new cost-saving solutions. A leader in the insurtech sector, InsuraGuest continues to expand its already impressive reach into multiple insurance markets. A recent article discussing this reads, “The company’s first target is the hospitality sector with intent to dominate what looks to be an incredibly lucrative segment. InsuraGuest Technologies’ latest landmark is the…

WednesdayFeb 10, 2021 1:58 pm

QualityStocksNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Secures $24.2M in Initial Public Offering

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company that offers novel and proprietary alternatives for treating mild-to-moderate obstructive sleep apnea, has closed its initial public offering of 4,025,000 shares of its common stock, including an additional 525,000 shares per the full exercise of the over-allotment option granted to the underwriters. According to the update, Vivos Therapeutics secured approximately $24.2 million in gross proceeds, with each of the shares sold at the public offering price of $6.00. The common stock shares began trading on the Nasdaq Capital Market under the ticker symbol "VVOS" on Friday, Dec. 11, 2020. ROTH Capital Partners…

WednesdayFeb 10, 2021 1:51 pm

QualityStocksNewsBreaks – Knightscope Inc. Secures Order from Aerospace Client

Knightscope, a developer of advanced physical security technologies utilizing fully autonomous security robots (“ASRs”), has announced its receipt of a purchase order from a privately held American aerospace and national security contractor. According to the update, the company is excited to provide an innovative solution for the new client for an undisclosed mission at an undisclosed location. To view the full update, visit https://ibn.fm/S8Vtc About Knightscope Knightscope is an advanced security technology company based in Silicon Valley that builds fully autonomous security robots (“ASRs”) that deter, detect and report. The company’s long-term ambition is to make the United States of…

WednesdayFeb 10, 2021 1:14 pm

QualityStocksNewsBreaks – Uranium Energy Corp. (NYSE American: UEC) CEO Guest on Latest The Bell2Bell Podcast Episode

Uranium Energy (NYSE American: UEC) president and CEO Amir Adnani is the featured guest on the most recent episode of The Bell2Bell Podcast. Hosted by Stuart Smith, The Bell2Bell Podcast, which is an InvestorBrandNework offering, provides insightful updates and inspiring interviews with executives operating in fast-moving industries. During his segment, Adnani provided an overview of UEC’s business model, noting that the company develops uranium projects using the in-situ recovery method, which is both low cost and environmentally friendly. Adnani talked about a few of the company’s projects and operations, including its fully licensed Hobson Processing Facility, one of only a…

WednesdayFeb 10, 2021 12:50 pm

QualityStocksNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Releases Q3 Financial Report

Canopy Rivers (TSX: RIV) (OTC: CNPOF), an investment and acquisition company specializing in cannabis, has shared financial numbers for its most recent period, the three and nine months ended Dec. 31, 2020. The announcement included both unaudited condensed interim consolidated financial statements and management's discussion and analysis ("MD&A"). Numbers in the report indicate that Canopy Rivers’ comprehensive income was $82.2 million, which the company notes was driven by an increase in the value of its investment in TerrAscend. The company also announced a “transformative and accretive” transaction with Canopy Growth; the transaction is scheduled to close by the end of February…

WednesdayFeb 10, 2021 12:37 pm

QualityStocksNewsBreaks – LexaGene Holdings Inc. (TSXV: LXG) (OTCQB: LXXGF) Configures MiQLab(TM) to Detect Variants of COVID-19 Pathogen

LexaGene Holdings (TSXV: LXG) (OTCQB: LXXGF), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, today announced that it has successfully configured a MiQLab(TM) system to detect mutant sequences unique to the United Kingdom (“UK, B.1.1.7”) 1 and South African (“SA, B.1.351”) 2 variants of SARS-CoV-2, the pathogen that causes COVID-19. “Just three weeks ago, we designed assays to detect the UK and SA variants to demonstrate proof-of-principle that these assays could be quickly ported onto the MiQLab,” said Dr. Jack Regan, LexaGene’s CEO and founder. “After just two full work days of having these reagents in-house,…

Site Search

Company Search

Category: QualityStocksNewsBreaks